Back to Search
Start Over
2015 NCCN Guidelines for Thyroid Carcinoma Recommend LENVIMA(TM) (lenvatinib) as Preferred Agent
- Source :
- PR Newswire. October 8, 2015
- Publication Year :
- 2015
-
Abstract
- WOODCLIFF LAKE, N.J., Oct. 8, 2015 /PRNewswire/ -- Eisai Inc. announced the decision of the National Comprehensive Cancer Network[sup.] (NCCN[sup.] ) to recommend LENVIMA(TM) (lenvatinib) as the preferred agent for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.430968657